Covered recipient · General Payments record
MANIK GOEL
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$2,737.83
- Reported across 69 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $442.52 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $316.04 | 13 |
| Alcon Laboratories Inc | $49.23 | 1 |
| Dompe US, Inc. | $32.34 | 1 |
| Amgen Inc. | $16.91 | 1 |
| Rayner Intraocular Lenses Limited | $14.37 | 1 |
| Bausch & Lomb Americas Inc. | $13.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.21 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103807614 | CMS |
| ABBVIE INC. | $13.32 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103807616 | CMS |
| ABBVIE INC. | $7.53 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103807618 | CMS |
| ABBVIE INC. | $24.83 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103807620 | CMS |
| ABBVIE INC. | $14.76 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103807622 | CMS |
| ABBVIE INC. | $22.55 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103807624 | CMS |
| ABBVIE INC. | $31.08 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103807626 | CMS |
| ABBVIE INC. | $11.40 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103807628 | CMS |
| ABBVIE INC. | $99.12 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103807630 | CMS |
| ABBVIE INC. | $13.70 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103807632 | CMS |
| ABBVIE INC. | $23.40 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103807634 | CMS |
| ABBVIE INC. | $12.51 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103807636 | CMS |
| ABBVIE INC. | $20.63 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103807638 | CMS |
| Alcon Vision LLC | $49.23 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110585707 | CMS |
| Amgen Inc. | $16.91 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111585171 | CMS |
| Bausch & Lomb Americas Inc. | $13.63 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140400106 | CMS |
| Dompe US, Inc. | $32.34 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151410107 | CMS |
| Rayner Intraocular Lenses Limited | $14.37 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1076273648 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.